Menopause Market Size, Share & Trends Report

Menopause Market Size, Share & Trends Analysis Report By Treatment (Dietary Supplements, OTC Pharma Products), By Region (North America, Europe, Latin America), And Segment Forecasts, 2024 - 2030

  • Report ID: GVR-4-68039-434-2
  • Number of Report Pages: 100
  • Format: PDF, Horizon Databook
  • Historical Range: 2018 - 2022
  • Forecast Period: 2024 - 2030 
  • Industry: Healthcare

Table of Contents

Chapter 1. Menopause Market: Methodology and Scope
                      1.1. Market Segmentation and Scope
                          1.1.1. Treatment Segment
                      1.2. Regional Scope
                      1.3. Estimates And Forecast Timeline
                      1.4. Objectives
                      1.5. Research Methodology
                      1.6. Information Procurement
                          1.6.1. Purchased Database
                          1.6.2. Gvr’s Internal Database
                          1.6.3. Secondary Sources
                          1.6.4. Primary Research
                      1.7. Information Or Data Analysis
                          1.7.1. Data Analysis Models
                      1.8. Market Formulation & Validation
                      1.9. Commodity Flow Analysis
                      1.10. List of Secondary Sources
                      1.11. List of Abbreviations
Chapter 2. Menopause Market: Executive Summary
                      2.1. Market Snapshot
                      2.2. Segment Snapshot
                      2.3. Competitive Landscape Snapshot
Chapter 3. Menopause Market: Market Variables, Trends, & Scope
                      3.1. Market Segmentation and Scope
                      3.2. Market Lineage Outlook
                          3.2.1. Parent Market Outlook
                          3.2.2. Related/Ancillary Market Outlook
                      3.3. Market Trends and Outlook
                      3.4. Market Dynamics
                          3.4.1. Growing number of women undergoing menopause
                          3.4.2. Increasing awareness about menopause and its treatment
                          3.4.3. Growing opportunities and innovations in menopause treatment
                          3.4.4. Increasing research supporting advantages of dietary supplements
                      3.5. Market Restraint Analysis
                          3.5.1. Social stigma associated with menopause and adverse effects of products
                          3.5.2. Lack of well-defined regulations
                      3.6. Business Environment Analysis
                          3.6.1. PESTLE Analysis
                          3.6.2. Porter’s Five Forces Analysis
                      3.7. COVID-19 Impact Analysis
Chapter 4. Treatment Business Analysis
                      4.1. Menopause Market: Treatment Movement Analysis
                      4.2. Dietary Supplements
                          4.2.1. Dietary Supplements Market, 2018 - 2030 (USD Million)
                      4.3. OTC Pharma Products
                          4.3.1. OTC Pharma Products Market, 2018 - 2030 (USD Million)
                          4.3.2. Hormonal Products
                             4.3.2.1.1. Hormonal Products Market, 2018 - 2030 (USD Million)
                          4.3.3. Non-hormonal Products
                             4.3.3.1.1. Non-hormonal Products Market, 2018 - 2030 (USD Million)
Chapter 5. Regional Business Analysis
                      5.1. Menopause Market Share By Region, 2023 & 2030
                      5.2. North America
                          5.2.1. North America Menopause Market, 2018 - 2030 (USD Million)
                           5.2.2. U.S.
                              5.2.2.1. Key Country Dynamics
                              5.2.2.2. Regulatory Framework/Scenario
                              5.2.2.3. Competitive Scenario
                              5.2.2.4. U.S. Menopause Market, 2018 - 2030 (USD Million)
                          5.2.3. Canada
                              5.2.3.1. Key Country Dynamics
                              5.2.3.2. Regulatory Framework/Scenario
                              5.2.3.3. Competitive Scenario
                              5.2.3.4. Canada Menopause Market, 2018 - 2030 (USD Million)
                      5.3. Europe
                          5.3.1. Europe Menopause Market, 2018 - 2030 (USD Million)
                          5.3.2. UK
                              5.3.2.1. Key Country Dynamics
                              5.3.2.2. Regulatory Framework/Scenario
                              5.3.2.3. Competitive Scenario
                              5.3.2.4. Germany Menopause Market, 2018 - 2030 (USD Million)
                          5.3.3. Germany
                              5.3.3.1. Key Country Dynamics
                              5.3.3.2. Regulatory Framework/Scenario
                              5.3.3.3. Competitive Scenario
                              5.3.3.4. UK Menopause Market, 2018 - 2030 (USD Million)
                          5.3.4. France
                              5.3.4.1. Key Country Dynamics
                              5.3.4.2. Regulatory Framework/Scenario
                              5.3.4.3. Competitive Scenario
                              5.3.4.4. France Menopause Market, 2018 - 2030 (USD Million)
                          5.3.5. Italy
                              5.3.5.1. Key Country Dynamics
                              5.3.5.2. Regulatory Framework/Scenario
                              5.3.5.3. Competitive Scenario
                              5.3.5.4. Italy Menopause Market, 2018 - 2030 (USD Million)
                          5.3.6. Spain
                              5.3.6.1. Key Country Dynamics
                              5.3.6.2. Regulatory Framework/Scenario
                              5.3.6.3. Competitive Scenario
                              5.3.6.4. Spain Menopause Market, 2018 - 2030 (USD Million)
                          5.3.7. Sweden
                              5.3.7.1. Key Country Dynamics
                              5.3.7.2. Regulatory Framework/Scenario
                              5.3.7.3. Competitive Scenario
                              5.3.7.4. Sweden Menopause Market, 2018 - 2030 (USD Million)
                          5.3.8. Norway
                              5.3.8.1. Key Country Dynamics
                              5.3.8.2. Regulatory Framework/Scenario
                              5.3.8.3. Competitive Scenario
                              5.3.8.4. Norway Menopause Market, 2018 - 2030 (USD Million)
                          5.3.9. Denmark
                              5.3.9.1. Key Country Dynamics
                              5.3.9.2. Regulatory Framework/Scenario
                              5.3.9.3. Competitive Scenario
                              5.3.9.4. Denmark Menopause Market, 2018 - 2030 (USD Million)
                      5.4. Asia Pacific
                          5.4.1. Asia Pacific Menopause Market, 2018 - 2030 (USD Million)
                          5.4.2. Japan
                              5.4.2.1. Key Country Dynamics
                              5.4.2.2. Regulatory Framework/Scenario
                              5.4.2.3. Competitive Scenario
                              5.4.2.4. Japan Menopause Market, 2018 - 2030 (USD Million)
                          5.4.3. China
                              5.4.3.1. Key Country Dynamics
                              5.4.3.2. Regulatory Framework/Scenario
                              5.4.3.3. Competitive Scenario
                              5.4.3.4. China Menopause Market, 2018 - 2030 (USD Million)
                          5.4.4. India
                              5.4.4.1. Key Country Dynamics
                              5.4.4.2. Regulatory Framework/Scenario
                              5.4.4.3. Competitive Scenario
                              5.4.4.4. India Menopause Market, 2018 - 2030 (USD Million)
                          5.4.5. Australia
                              5.4.5.1. Key Country Dynamics
                              5.4.5.2. Regulatory Framework/Scenario
                              5.4.5.3. Competitive Scenario
                              5.4.5.4. Australia Menopause Market, 2018 - 2030 (USD Million)
                          5.4.6. Thailand
                              5.4.6.1. Key Country Dynamics
                              5.4.6.2. Regulatory Framework/Scenario
                              5.4.6.3. Competitive Scenario
                              5.4.6.4. Thailand Menopause Market, 2018 - 2030 (USD Million)
                          5.4.7. South Korea
                              5.4.7.1. Key Country Dynamics
                              5.4.7.2. Regulatory Framework/Scenario
                              5.4.7.3. Competitive Scenario
                              5.4.7.4. South Korea Menopause Market, 2018 - 2030 (USD Million)
                      5.5. Latin America
                          5.5.1. Latin America Menopause Market, 2018 - 2030 (USD Million)
                          5.5.2. Brazil
                              5.5.2.1. Key Country Dynamics
                              5.5.2.2. Regulatory Framework/Scenario
                              5.5.2.3. Competitive Scenario
                              5.5.2.4. Brazil Menopause Market, 2018 - 2030 (USD Million)
                          5.5.3. Mexico
                              5.5.3.1. Key Country Dynamics
                              5.5.3.2. Regulatory Framework/Scenario
                              5.5.3.3. Competitive Scenario
                              5.5.3.4. Mexico Menopause Market, 2018 - 2030 (USD Million)
                          5.5.4. Argentina
                              5.5.4.1. Key Country Dynamics
                              5.5.4.2. Regulatory Framework/Scenario
                              5.5.4.3. Competitive Scenario
                              5.5.4.4. Argentina Menopause Market, 2018 - 2030 (USD Million)
                      5.6. MEA
                          5.6.1. MEA Menopause Market, 2018 - 2030 (USD Million)
                          5.6.2. South Africa
                              5.6.2.1. Key Country Dynamics
                              5.6.2.2. Regulatory Framework/Scenario
                              5.6.2.3. Competitive Scenario
                              5.6.2.4. South Africa Menopause Market, 2018 - 2030 (USD Million)
                          5.6.3. Saudi Arabia
                              5.6.3.1. Key Country Dynamics
                              5.6.3.2. Regulatory Framework/Scenario
                              5.6.3.3. Competitive Scenario
                              5.6.3.4. Saudi Arabia Menopause Market, 2018 - 2030 (USD Million)
                          5.6.4. UAE
                              5.6.4.1. Key Country Dynamics
                              5.6.4.2. Regulatory Framework/Scenario
                              5.6.4.3. Competitive Scenario
                              5.6.4.4. UAE Menopause Market, 2018 - 2030 (USD Million)
                          5.6.5. Kuwait
                              5.6.5.1. Key Country Dynamics
                              5.6.5.2. Regulatory Framework/Scenario
                              5.6.5.3. Competitive Scenario
                              5.6.5.4. Kuwait Menopause Market, 2018 - 2030 (USD Million)
Chapter 6. Competitive Landscape
                      6.1. Company Categorization
                      6.2. Strategy Mapping
                          6.2.1. Merger& Acquisition
                          6.2.2. Collaborations
                          6.2.3. New Product Launch
                      6.3. Participant’s overview
                          6.3.1. Bayer AG
                              6.3.1.1. Overview
                              6.3.1.2. Financial Performance
                              6.3.1.3. Product Benchmarking
                              6.3.1.4. Strategic Initiatives
                          6.3.2. Theramex
                              6.3.2.1. Overview
                              6.3.2.2. Financial Performance
                              6.3.2.3. Product Benchmarking
                              6.3.2.4. Strategic Initiatives
                          6.3.3. Abbvie Inc.
                              6.3.3.1. Overview
                              6.3.3.2. Financial Performance
                              6.3.3.3. Product Benchmarking
                              6.3.3.4. Strategic Initiatives
                          6.3.4. Abbott
                              6.3.4.1. Overview
                              6.3.4.2. Financial Performance
                              6.3.4.3. Product Benchmarking
                              6.3.4.4. Strategic Initiatives
                          6.3.5. Pure Encapsulations, LLC
                              6.3.5.1. Overview
                              6.3.5.2. Financial Performance
                              6.3.5.3. Product Benchmarking
                              6.3.5.4. Strategic Initiatives
                          6.3.6. Dr. Reddy’s Laboratories Ltd.
                              6.3.6.1. Overview
                              6.3.6.2. Financial Performance
                              6.3.6.3. Product Benchmarking
                              6.3.6.4. Strategic Initiatives
                          6.3.7. Rainbow Light
                              6.3.7.1. Overview
                              6.3.7.2. Financial Performance
                              6.3.7.3. Product Benchmarking
                              6.3.7.4. Strategic Initiatives
                          6.3.8. PADAGIS LLC
                              6.3.8.1. Overview
                              6.3.8.2. Financial Performance
                              6.3.8.3. Product Benchmarking
                              6.3.8.4. Strategic Initiatives


List of Tables

Table 1. List of secondary sources
Table 2. List of abbreviation
Table 3. Global dietary supplements market estimates and forecast, 2018 - 2030 (USD Million)
Table 4. Global OTC pharma products market estimates and forecast, 2018 - 2030 (USD Million)
Table 5. North America menopause market estimates and forecast, 2018 - 2030 (USD Million)
Table 6. North America menopause market revenue estimates and forecast by treatment, 2018 - 2030 (USD Million)
Table 7. U.S. menopause market estimates and forecast, 2018 - 2030 (USD Million)
Table 8. U.S. menopause market revenue estimates and forecast by treatment, 2018 - 2030 (USD Million)
Table 9. Canada menopause market estimates and forecast, 2018 - 2030 (USD Million)
Table 10. Canada menopause market revenue estimates and forecast by treatment, 2018 - 2030 (USD Million)
Table 11. Europe menopause market estimates and forecast, 2018 - 2030 (USD Million)
Table 12. Europe menopause market revenue estimates and forecast by treatment, 2018 - 2030 (USD Million)
Table 13. UK menopause market estimates and forecast, 2018 - 2030 (USD Million)
Table 14. UK menopause market revenue estimates and forecast by treatment, 2018 - 2030 (USD Million)
Table 15. Germany menopause market estimates and forecast, 2018 - 2030 (USD Million)
Table 16. Germany menopause market revenue estimates and forecast by treatment, 2018 - 2030 (USD Million)
Table 17. France menopause market estimates and forecast, 2018 - 2030 (USD Million)
Table 18. France menopause market revenue estimates and forecast by treatment, 2018 - 2030 (USD Million)
Table 19. Italy menopause market estimates and forecast, 2018 - 2030 (USD Million)
Table 20. Italy menopause market revenue estimates and forecast by treatment, 2018 - 2030 (USD Million)
Table 21. Spain menopause market estimates and forecast, 2018 - 2030 (USD Million)
Table 22. Spain menopause market revenue estimates and forecast by treatment, 2018 - 2030 (USD Million)
Table 23. Austria menopause market estimates and forecast, 2018 - 2030 (USD Million)
Table 24. Austria menopause market revenue estimates and forecast by treatment, 2018 - 2030 (USD Million)
Table 25. Asia Pacific menopause market estimates and forecast, 2018 - 2030 (USD Million)
Table 26. Asia Pacific menopause market revenue estimates and forecast by treatment, 2018 - 2030 (USD Million)
Table 27. China menopause market estimates and forecast, 2018 - 2030 (USD Million)
Table 28. China menopause market revenue estimates and forecast by treatment, 2018 - 2030 (USD Million)
Table 29. Japan menopause market estimates and forecast, 2018 - 2030 (USD Million)
Table 30. Japan menopause market revenue estimates and forecast by treatment, 2018 - 2030 (USD Million)
Table 31. India menopause market estimates and forecast, 2018 - 2030 (USD Million)
Table 32. India menopause market revenue estimates and forecast by treatment, 2018 - 2030 (USD Million)
Table 33. South Korea menopause market estimates and forecast, 2018 - 2030 (USD Million)
Table 34. South Korea menopause market revenue estimates and forecast by treatment, 2018 - 2030 (USD Million)
Table 35. Latin America menopause market estimates and forecast, 2018 - 2030 (USD Million)
Table 36. Latin America menopause market revenue estimates and forecast by treatment, 2018 - 2030 (USD Million)
Table 37. Brazil menopause market estimates and forecast, 2018 - 2030 (USD Million)
Table 38. Brazil menopause market revenue estimates and forecast by treatment, 2018 - 2030 (USD Million)
Table 39. Mexico menopause market estimates and forecast, 2018 - 2030 (USD Million)
Table 40. Mexico menopause market revenue estimates and forecast by treatment, 2018 - 2030 (USD Million)
Table 41. Middle East & Africa (MEA) menopause market estimates and forecast, 2018 - 2030 (USD Million)
Table 42. Middle East & Africa (MEA) menopause market revenue estimates and forecast by treatment, 2018 - 2030 (USD Million)
Table 43. South Africa menopause market estimates and forecast, 2018 - 2030 (USD Million)
Table 44. South Africa menopause market revenue estimates and forecast by treatment, 2018 - 2030 (USD Million)


List of Figures

Fig 1. Menopause market segmentation
Fig 2. Market research process
Fig 3. Information procurement
Fig 4. Primary research pattern
Fig 5. Market research approaches
Fig 6. Value - chain - based sizing & forecasting
Fig 7. QFD modeling for market share assessment
Fig 8. Market formulation & validation
Fig 9. Menopause market outlook 2023 (USD Million)
Fig 10. Penetration & growth prospect mapping
Fig 11. Market driver relevance analysis (Current & future impact)
Fig 12. Market restraint relevance analysis (Current & future impact)
Fig 13. Menopause market: Treatment movement analysis
Fig 14. Menopause market treatment outlook: Key takeaways
Fig 15. Dietary supplements market, 2018 - 2030 (USD Million)
Fig 16. OTC pharma products market, 2018 - 2030 (USD Million)
Fig 17. Hormonal products market, 2018 - 2030 (USD Million)
Fig 18. Non - hormonal products market, 2018 - 2030 (USD Million)
Fig 19. Regional marketplace: key takeaways
Fig 20. Regional outlook, 2023 & 2030
Fig 21. Global menopause market: region movement analysis
Fig 22. North America menopause market, 2018 - 2030 (USD Million)
Fig 23. U.S. key country dynamics
Fig 24. U.S. menopause market, 2018 - 2030 (USD Million)
Fig 25. Canada key country dynamics
Fig 26. Canada menopause market, 2018 - 2030 (USD Million)
Fig 27. Europe menopause market, 2018 - 2030 (USD Million)
Fig 28. UK key country dynamics
Fig 29. UK menopause market, 2018 - 2030 (USD Million)
Fig 30. Germany key country dynamics
Fig 31. Germany menopause market, 2018 - 2030 (USD Million)
Fig 32. France key country dynamics
Fig 33. France menopause market, 2018 - 2030 (USD Million)
Fig 34. Italy key country dynamics
Fig 35. Italy menopause market, 2018 - 2030 (USD Million)
Fig 36. Spain key country dynamics
Fig 37. Spain menopause market, 2018 - 2030 (USD Million)
Fig 38. Sweden key country dynamics
Fig 39. Sweden menopause market, 2018 - 2030 (USD Million)
Fig 40. Norway key country dynamics
Fig 41. Norway menopause market, 2018 - 2030 (USD Million)
Fig 42. Denmark key country dynamics
Fig 43. Denmark menopause market, 2018 - 2030 (USD Million)
Fig 44. Asia Pacific menopause market, 2018 - 2030 (USD Million)
Fig 45. Japan key country dynamics
Fig 46. Japan menopause market, 2018 - 2030 (USD Million)
Fig 47. China key country dynamics
Fig 48. China menopause market, 2018 - 2030 (USD Million)
Fig 49. India key country dynamics
Fig 50. India menopause market, 2018 - 2030 (USD Million)
Fig 51. Australia key country dynamics
Fig 52. Australia menopause market, 2018 - 2030 (USD Million)
Fig 53. Thailand key country dynamics
Fig 54. Thailand menopause market, 2018 - 2030 (USD Million)
Fig 55. South Korea key country dynamics
Fig 56. South Korea menopause market, 2018 - 2030 (USD Million)
Fig 57. Latin America menopause market, 2018 - 2030 (USD Million)
Fig 58. Brazil key country dynamics
Fig 59. Brazil menopause market, 2018 - 2030 (USD Million)
Fig 60. Mexico key country dynamics
Fig 61. Mexico menopause market, 2018 - 2030 (USD Million)
Fig 62. Argentina key country dynamics
Fig 63. Argentina menopause market, 2018 - 2030 (USD Million)
Fig 64. Middle East and Africa menopause market, 2018 - 2030 (USD Million)
Fig 65. South Africa key country dynamics
Fig 66. South Africa menopause market, 2018 - 2030 (USD Million)
Fig 67. Saudi Arabia key country dynamics
Fig 68. Saudi Arabia menopause market, 2018 - 2030 (USD Million)
Fig 69. UAE key country dynamics
Fig 70. UAE menopause market, 2018 - 2030 (USD Million)
Fig 71. Kuwait key country dynamics
Fig 72. Kuwait menopause market, 2018 - 2030 (USD Million)
Fig 73. Company market position analysis
Fig 74. Company/competition categorization
Fig 75. Strategy mapping

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon